Changing the type of desks students use in schools could impact the health of our nation…. Obesity is a big concern and some adults are opting to use standing desks in favor of their standard office chairs as a way to avoid sitting during long hours at work, believing that …

ACTIVE Network, LLC $1.99 iOS/Android   Although many of our patients may not think running a 5K will ever be possible for them, this app shows that this goal may be more achievable than they believe. It offers very easy step-by-step guidelines and provides support throughout the training period. The …

This week we find that a lot of information is coming out the EASD meeting in Vienna, and much of it has to do with the use of pump therapy in patient care. There is also a great article that dispels any concerns you may have about starting your patients …

The FDA works really hard these days to come up with new brand names that will lessen the chance of drug choice confusion. Often times we wonder how they can come up with these names and what meaning they have. With this in mind, this week’s Diabetes Disaster Averted points …

In this second set of Homerun Slides focusing on Type 1 Diabetes and Psychoeducation, we review the emotions that both children and parents may experience after an initial diagnosis and some of the challenges that both face in managing a child’s type 1 diabetes… To download the complete set of …

I was reviewing a client’s insulin administration. She was administering Levemir (insulin detemir), 60 units, with a FlexPen. She said that she just dialed the dose to the maximum it would allow her as she knew it only would dial to 60 units. She did not confirm the dose visually. Although …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Diabetic ketoacidosis (DKA) is a state of severe uncontrolled diabetes caused by insulin deficiency. It is characterised by hyperglycaemia, hyperketonaemia and metabolic acidosis, and has been somewhat arbitrarily divided into mild, moderate and severe based upon biochemical and clinical features (Table 12.1)….

FDA Approves New Once-Weekly GLP-1  See this week’s Item #1.

Trulicity™ (dulaglutide) Trulicity (dulaglutide) is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) just approved by the FDA that offers adults with type 2 diabetes once-weekly dosing in the Trulicity pen, which has a pre-attached, hidden needle and requires no reconstitution. Prescribing Information   

Patient Handout: Your Job Your Rights (PDF)  Important information for your patients. This updated four-panel brochure addresses the issues of discrimination based on diabetes in the workplace. It outlines the laws, personal rights, federally mandated accommodations, and how to address discrimination. Know Your Rights (English) Know Your Rights (Spanish)